Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech
Pharma
PwC projects continued growth for rest of 2026, fueled by M&A
With pharma and life sciences deals surpassing $65 billion in Q1, analysts from PwC have declared the “biopharma ecosystem is back to full health.”
Kevin Dunleavy
Jun 17, 2026 5:00am
US healthcare, life sci could benefit from disruption: poll
May 27, 2026 8:00am
BIO comes out swinging with 'Fight of Our Lives' campaign
Apr 17, 2026 6:17am
Ansa snares $54.4M in series B to boost its DNA synthesis tech
Oct 2, 2025 8:50am
Aadi takes flight with new moniker: Whitehawk Therapeutics
Mar 18, 2025 4:45pm
Biotech rebrands as Octavian, plans recovery from past setbacks
Feb 11, 2025 11:30am